| Abstract: A planar copper complex Cu(L)2, HL=(E)-benzyl-2-(4-formylbenzylidene)- Hydrazinecarbodithioate, has been prepared via the template effect of copper ion. Crystal structure of the complex was determined by X-ray single-crystal diffraction analysis. The crystal data for this complex: Orthorhombic, space group Pbcn, a=2.250 0(14) nm, b=1.660 0(11) nm, c=0.830 4(5) nm, V=3.102(3) nm3, Z=4, μ=1.011 mm-1, Dc=1.478 g·cm-3, F(000)=1 420, R1=0.050 1, wR2=0.087 2 (observed reflections with I>2σ(I)) and R1=0.129 1, wR2=0.100 9 (all reflections) GOF=1.011. In the compound, Cu(Ⅱ) atom is four-coordinated with two N atoms and two S atoms from two bidentate ligands and located in the inversion center. The preliminary bioassay indicates that the complex exhibits distinct antitumor activity. CCDC: 763155. |
